
    
      All potential subject coming to a site looking to purchase EC will be offered to participate
      in the study. Subjects who meet the initial screening inclusion criteria for the study will
      review package information and make a self-selection and purchase decision. Subjects who meet
      all remaining inclusion criteria will purchase ellaÂ®, and use based on their understanding of
      the package information.

      Follow-up data regarding product use and adverse events will be obtained during telephone
      interviews at approximately Week-2 and Week-6 after the date the subject was dispensed study
      product.
    
  